No title
Background and objectives: Treatment-resistant schizophrenia (TRS) is a severe subtype of schizophrenia. While negative and disorganised symptoms have been associated with cognitive dysfunction, the underlying neurobiological mechanisms remain unclear. Plasma neurofilament light chain protein (NfL), a biomarker of neuroaxonal damage, has shown promising associations in TRS. This study investigates
